These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Studies on the possible contamination of transfer factor preparations with bacterial endotoxins]. Fumarola D; Panaro A Pathologica; 1976; 68(977-978):153-8. PubMed ID: 1018976 [No Abstract] [Full Text] [Related]
3. Toxicity of interferon. Priestman TJ; Lucken RN; Finter NB Br Med J (Clin Res Ed); 1981 Aug; 283(6290):562. PubMed ID: 6167311 [No Abstract] [Full Text] [Related]
4. Improved method for the removal of endotoxin from DNA. Montbriand PM; Malone RW J Biotechnol; 1996 Jan; 44(1-3):43-6. PubMed ID: 8717385 [TBL] [Abstract][Full Text] [Related]
5. [Role of possible endotoxin contaminants present in some preparations of biological products and injectable drugs]. Fumarola D Ann Sclavo; 1978; 20(4):546-57. PubMed ID: 380476 [TBL] [Abstract][Full Text] [Related]
6. Thrombogenic effects of some concentrates of coagulation factors: a possible role of contaminating endotoxin. Fumarola D Haematologica; 1978 Apr; 63(2):224. PubMed ID: 98405 [No Abstract] [Full Text] [Related]
8. A cell line assay system for predicting the response of human blood to endotoxin. Yamamoto A; Sakai T; Ochiai M; Kamachi K; Kataoka M; Toyoizumi H; Horiuchi Y Jpn J Infect Dis; 2003 Jun; 56(3):93-100. PubMed ID: 12944673 [TBL] [Abstract][Full Text] [Related]
9. Interferon: an early evaluation. McCredie KB; Moore MS J Okla State Med Assoc; 1980 Sep; 73(9):325-8. PubMed ID: 6160226 [No Abstract] [Full Text] [Related]
10. Pyrogenicity versus endotoxicity: which is more significant? Shanbrom E Prog Clin Biol Res; 1982; 93():105-13. PubMed ID: 6181526 [No Abstract] [Full Text] [Related]
11. Possible role of contaminating endotoxin in radiographic contrast media reactions. Fumarola D Boll Ist Sieroter Milan; 1979 Jan; 57(6):848-9. PubMed ID: 552831 [No Abstract] [Full Text] [Related]
13. Interferon in human serum after injection of endotoxin. Sauter C; Wolfensberger C Lancet; 1980 Oct; 2(8199):852-3. PubMed ID: 6159510 [No Abstract] [Full Text] [Related]
14. Some comments on interferon. Gams RA Ala J Med Sci; 1980 Apr; 17(2):120-1. PubMed ID: 6158273 [No Abstract] [Full Text] [Related]
15. The natural killer cell-interferon system in human carcinoma--its relation to interferon cancer treatment trials. Ching NP; Ching CY; Jim EL; Loh KK; Oishi N; Yim DW Hawaii Med J; 1984 Oct; 43(10):368-72. PubMed ID: 6210268 [No Abstract] [Full Text] [Related]